Table of Contents
ISRN Inflammation
Volume 2012 (2012), Article ID 471617, 11 pages
http://dx.doi.org/10.5402/2012/471617
Research Article

Expression Analysis of Cytokine and Chemokine Genes during the Natural Course of Murine Experimental Autoimmune Uveoretinitis

Department of Ophthalmology, Osaka University Graduate School of Medicine, E7, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan

Received 8 July 2012; Accepted 13 August 2012

Academic Editors: B. Frey, B. Kim, A. Merched, and M. Reale

Copyright © 2012 Noriyasu Hashida et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. R. Caspi, F. G. Roberge, and C. G. McCallister, “T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat,” Journal of Immunology, vol. 136, no. 3, pp. 928–933, 1986. View at Google Scholar · View at Scopus
  2. C. C. Chan, R. B. Nussenblatt, and B. Wiggert, “Immunohistochemical analysis of experimental autoimmune uveoretinitis (EAU) induced by interphotoreceptor retinoid-binding protein (IRBP) in the rat,” Immunological Investigations, vol. 16, no. 1, pp. 63–74, 1987. View at Google Scholar · View at Scopus
  3. R. R. Caspi, C. C. Chan, B. Wiggert, and G. J. Chader, “The mouse as a model of experimental autoimmune uveoretinitis (EAU),” Current Eye Research, vol. 9, pp. 169–174, 1990. View at Google Scholar · View at Scopus
  4. R. R. Caspi, P. B. Silver, C. C. Chan et al., “Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response,” Journal of Immunology, vol. 157, no. 6, pp. 2668–2675, 1996. View at Google Scholar · View at Scopus
  5. J. P. Faure, “Autoimmunity and the retina,” Current Topics in Eye Research, vol. 2, pp. 215–302, 1980. View at Google Scholar · View at Scopus
  6. W. B. Wacker, L. A. Donoso, and C. M. Kalsow, “Experimental allergic uveitis. Isolation, characterization, and localization of a soluble uveitopathogenic antigen from bovine retina,” Journal of Immunology, vol. 119, no. 6, pp. 1949–1958, 1977. View at Google Scholar · View at Scopus
  7. D. Avichezer, P. B. Silver, C. C. Chan, B. Wiggert, and R. R. Caspi, “Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype,” Investigative Ophthalmology & Visual Science, vol. 41, no. 1, pp. 127–131, 2000. View at Google Scholar · View at Scopus
  8. K. Yamaki, K. Gocho, K. Hayakawa, I. Kondo, and S. Sakuragi, “Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease,” Journal of Immunology, vol. 165, no. 12, pp. 7323–7329, 2000. View at Google Scholar · View at Scopus
  9. D. Rossi and A. Zlotnik, “The biology of chemokines and their receptors,” Annual Review of Immunology, vol. 18, pp. 217–242, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. A. M. Abu El-Asrar, S. Struyf, S. A. Al-Kharashi, L. Missotten, J. Van Damme, and K. Geboes, “The T-lymphocyte chemoattractant Mig is highly expressed in vernal keratoconjunctivitis,” American Journal of Ophthalmology, vol. 136, no. 5, pp. 853–860, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Loetscher, B. Gerber, P. Loetscher et al., “Chemokine receptor specific for IP10 and Mig: structure, function, and expression in activate T-Lymphocytes,” Journal of Experimental Medicine, vol. 184, no. 3, pp. 963–969, 1996. View at Google Scholar · View at Scopus
  12. K. E. Cole, C. A. Strick, T. J. Paradis et al., “Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3,” Journal of Experimental Medicine, vol. 187, no. 12, pp. 2009–2021, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Bonecchi, G. Bianchi, P. P. Bordignon et al., “Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s,” Journal of Experimental Medicine, vol. 187, no. 1, pp. 129–134, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Keino, M. Takeuchi, T. Kezuka, N. Yamakawa, R. Tsukahara, and M. Usui, “Chemokine and chemokine receptor expression during experimental autoimmune uveoretinitis in mice,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 241, no. 2, pp. 111–115, 2003. View at Google Scholar · View at Scopus
  15. A. Amadi-Obi, C. R. Yu, X. Liu et al., “TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1,” Nature Medicine, vol. 13, no. 6, pp. 711–718, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. E. Darnell Jr., I. M. Kerr, and G. R. Stark, “Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins,” Science, vol. 264, no. 5164, pp. 1415–1421, 1994. View at Google Scholar · View at Scopus
  17. Y. Wu, Y. Lin, W. Hou, Y. Wang, and B. Sun, “IFN-γ up-regulation of IL-12 beta 2 receptor is associated with experimental autoimmune uveitis susceptible B10.A mice, but not in EAU resistant BALB/c mice,” Journal of Neuroimmunology, vol. 137, no. 1-2, pp. 154–163, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. P. B. Thomas, T. Albini, R. K. Giri, R. F. See, M. Evans, and N. A. Rao, “The effects of atorvastatin in experimental autoimmune uveitis,” British Journal of Ophthalmology, vol. 89, no. 3, pp. 275–279, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. X. O. Yang, A. D. Panopoulos, R. Nurieva et al., “STAT3 regulates cytokine-mediated generation of inflammatory helper T cells,” Journal of Biological Chemistry, vol. 282, no. 13, pp. 9358–9363, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Hashida, N. Ohguro, K. Nakai et al., “Microarray analysis of cytokine and chemokine gene expression after prednisolone treatment in murine experimental autoimmune uveoretinitis,” Investigative Ophthalmology & Visual Science, vol. 46, no. 11, pp. 4224–4234, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Namba, K. Ogasawara, N. Kitaichi et al., “Amelioration of experimental autoimmune uveoretinitis by pretreatment with a pathogenic peptide in liposome and anti-CD40 ligand monoclonal antibody,” Journal of Immunology, vol. 165, no. 6, pp. 2962–2969, 2000. View at Google Scholar · View at Scopus
  23. S. R. Thurau, C. C. Chan, R. B. Nussenblatt, and R. R. Caspi, “Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals,” Clinical and Experimental Immunology, vol. 109, no. 2, pp. 370–376, 1997. View at Google Scholar · View at Scopus
  24. H. Dong, N. Toyoda, H. Yoneyama et al., “Gene expression profile analysis of the mouse liver during bacteria-induced fulminant hepatitis by a cDNA microarray system,” Biochemical and Biophysical Research Communications, vol. 298, no. 5, pp. 675–686, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. M. W. Pfaffl, G. W. Horgan, and L. Dempfle, “Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR,” Nucleic Acids Research, vol. 30, no. 9, article e36, 2002. View at Google Scholar · View at Scopus
  26. F. Ariani, F. Mari, C. Pescucci et al., “Real-time quantitative PCR as a routine method for screening large rearrangements in Rett syndrome: report of one case of MECP2 deletion and one case of MECP2 duplication,” Human Mutation, vol. 24, no. 2, pp. 172–177, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. M. F. Neurath, S. Finotto, and L. H. Glimcher, “The role of TH1/TH2 polarization in mucosal immunity,” Nature Medicine, vol. 8, no. 6, pp. 567–573, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. M. B. Eisen, P. T. Spellman, P. O. Brown, and D. Botstein, “Cluster analysis and display of genome-wide expression patterns,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 25, pp. 14863–14868, 1998. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Diskin, J. Kumar, Z. Cao et al., “Detection of differentially expressed glycogenes in trabecular meshwork of eyes with primary open-angle glaucoma,” Investigative Ophthalmology & Visual Science, vol. 47, no. 4, pp. 1491–1499, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Yoshimura, K. H. Sonoda, N. Ohguro et al., “Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis,” Rheumatology, vol. 48, no. 4, pp. 347–354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. E. F. Foxman, M. Zhang, S. D. Hurst et al., “Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation,” Journal of Immunology, vol. 168, no. 5, pp. 2483–2492, 2002. View at Google Scholar · View at Scopus
  32. B. Sun, L. V. Rizzo, S. H. Sun et al., “Genetic susceptibility to experimental autoimmune uveitis involves more than a predisposition to generate a T helper-1-like or a T helper-2-like response,” Journal of Immunology, vol. 159, no. 2, pp. 1004–1011, 1997. View at Google Scholar · View at Scopus
  33. M. Takeuchi, H. Yokoi, R. Tsukahara, J. I. Sakai, and M. Usui, “Differentiation of Th1 and Th2 cells in lymph nodes and spleens of mice during experimental autoimmune uveoretinitis,” Japanese Journal of Ophthalmology, vol. 45, no. 5, pp. 463–469, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. M. E. Gegg, R. Harry, D. Hankey et al., “Suppression of autoimmune retinal disease by lovastatin does not require Th2 cytokine induction,” Journal of Immunology, vol. 174, no. 4, pp. 2327–2335, 2005. View at Google Scholar · View at Scopus
  35. L. V. Rizzo, H. Xu, C. C. Chan, B. Wiggert, and R. R. Caspi, “IL-10 has a protective role in experimental autoimmune uveoretinitis,” International Immunology, vol. 10, no. 6, pp. 807–814, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. De Kozak, B. Thillaye-Goldenberg, M. C. Naud, A. Viana Da Costa, C. Auriault, and C. Verwaerde, “Inhibition of experimental autoimmune uveoretinitis by systemic and subconjunctival adenovirus-mediated transfer of the viral IL-10 gene,” Clinical and Experimental Immunology, vol. 130, no. 2, pp. 212–223, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. S. B. Su, R. S. Grajewski, D. Luger et al., “Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-gamma deficiency,” Investigative Ophthalmology & Visual Science, vol. 48, no. 10, pp. 4616–4625, 2007. View at Google Scholar
  38. C. E. Egwuagu, “STAT3 in CD4+ T helper cell differentiation and inflammatory diseases,” Cytokine, vol. 47, no. 3, pp. 149–156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. E. C. Kerr, B. J. E. Raveney, D. A. Copland, A. D. Dick, and L. B. Nicholson, “Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations,” Journal of Autoimmunity, vol. 31, no. 4, pp. 354–361, 2008. View at Publisher · View at Google Scholar · View at Scopus